| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 14.390 | 6.504 | 3.717 | 311 | 48 |
| Total Income - EUR | - | - | - | - | 4.851 | 40.675 | 11.023 | 3.715 | 311 | 48 |
| Total Expenses - EUR | - | - | - | - | 8.570 | 33.345 | 27.451 | 6.775 | 603 | 2.162 |
| Gross Profit/Loss - EUR | - | - | - | - | -3.719 | 7.330 | -16.427 | -3.060 | -292 | -2.114 |
| Net Profit/Loss - EUR | - | - | - | - | -3.719 | 7.190 | -16.472 | -3.149 | -292 | -2.114 |
| Employees | - | - | - | - | 2 | 2 | 2 | 1 | 0 | 0 |
Check the financial reports for the company - Bio-Xabon S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 6.197 | 3.787 | 1.999 | 1.516 | 452 |
| Current Assets | - | - | - | - | 29.266 | 1.618 | 1.224 | 1.448 | 2.088 | 0 |
| Inventories | - | - | - | - | 1.415 | 1.426 | 1.038 | 1.397 | 1.786 | 0 |
| Receivables | - | - | - | - | 7.986 | 158 | 155 | 0 | 55 | 0 |
| Cash | - | - | - | - | 19.865 | 34 | 31 | 51 | 247 | 0 |
| Shareholders Funds | - | - | - | - | -3.677 | 3.583 | -12.968 | -16.157 | -16.400 | -18.422 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 5.102 | 4.233 | 17.980 | 19.604 | 20.004 | 18.874 |
| Income in Advance | - | - | - | - | 27.840 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2042 - 2042" | |||||||||
| CAEN Financial Year |
2042
|
|||||||||
Comments - Bio-Xabon S.r.l.